• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022

    10/21/22 10:11:33 AM ET
    $ACI
    $ATSG
    $AXNX
    $AXTA
    Food Chains
    Consumer Staples
    Air Freight/Delivery Services
    Consumer Discretionary
    Get the next $ACI alert in real time by email

    Upgrades

    SVB Leerink upgraded the previous rating for Moderna Inc (NASDAQ:MRNA) from Underperform to Market Perform. Moderna earned $5.24 in the second quarter, compared to $6.46 in the year-ago quarter. The stock has a 52-week-high of $249.42 and a 52-week-low of $115.03. At the end of the last trading period, Moderna closed at $118.38.

    For Farmers & Merchants Bancorp Inc (NASDAQ:FMAO), Piper Sandler upgraded the previous rating of Underweight to Neutral. For the third quarter, Farmers & Merchants had an EPS of $0.68, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $42.13 and a 52-week-low of $25.17. At the end of the last trading period, Farmers & Merchants closed at $25.33.

    According to Truist Securities, the prior rating for AT&T Inc (NYSE:T) was changed from Hold to Buy. In the third quarter, AT&T showed an EPS of $0.68, compared to $0.87 from the year-ago quarter. The current stock performance of AT&T shows a 52-week-high of $27.48 and a 52-week-low of $14.46. Moreover, at the end of the last trading period, the closing price was at $16.74.

    For GFL Environmental Inc (NYSE:GFL), B of A Securities upgraded the previous rating of Neutral to Buy. For the second quarter, GFL Envirn had an EPS of $0.19, compared to year-ago quarter EPS of $0.08. The current stock performance of GFL Envirn shows a 52-week-high of $38.05 and a 52-week-low of $23.10. Moreover, at the end of the last trading period, the closing price was at $25.02.

    For Albertsons Companies Inc (NYSE:ACI), BMO Capital upgraded the previous rating of Underperform to Market Perform. In the second quarter, Albertsons Companies showed an EPS of $0.72, compared to $0.64 from the year-ago quarter. The current stock performance of Albertsons Companies shows a 52-week-high of $37.99 and a 52-week-low of $24.34. Moreover, at the end of the last trading period, the closing price was at $27.50.

    Needham upgraded the previous rating for Qualys Inc (NASDAQ:QLYS) from Hold to Buy. For the second quarter, Qualys had an EPS of $0.89, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $162.36 and a 52-week-low of $108.10. At the end of the last trading period, Qualys closed at $130.57.

    For HealthEquity Inc (NASDAQ:HQY), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the second quarter, HealthEquity showed an EPS of $0.33, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $74.10 and a 52-week-low of $43.98. At the end of the last trading period, HealthEquity closed at $73.98.

    According to Raymond James, the prior rating for Juniper Networks Inc (NYSE:JNPR) was changed from Outperform to Strong Buy. In the second quarter, Juniper Networks showed an EPS of $0.42, compared to $0.43 from the year-ago quarter. The current stock performance of Juniper Networks shows a 52-week-high of $38.14 and a 52-week-low of $25.18. Moreover, at the end of the last trading period, the closing price was at $27.61.

    See all analyst ratings upgrades.

    Downgrades

    For CVB Financial Corp (NASDAQ:CVBF), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the third quarter, CVB Financial showed an EPS of $0.46, compared to $0.37 from the year-ago quarter. The current stock performance of CVB Financial shows a 52-week-high of $28.25 and a 52-week-low of $21.36. Moreover, at the end of the last trading period, the closing price was at $27.50.

    According to Keefe, Bruyette & Woods, the prior rating for First Internet Bancorp (NASDAQ:INBK) was changed from Outperform to Market Perform. For the third quarter, First Internet had an EPS of $0.90, compared to year-ago quarter EPS of $1.27. The current stock performance of First Internet shows a 52-week-high of $53.56 and a 52-week-low of $24.50. Moreover, at the end of the last trading period, the closing price was at $24.57.

    Craig-Hallum downgraded the previous rating for First Internet Bancorp (NASDAQ:INBK) from Buy to Hold. For the third quarter, First Internet had an EPS of $0.90, compared to year-ago quarter EPS of $1.27. The current stock performance of First Internet shows a 52-week-high of $53.56 and a 52-week-low of $24.50. Moreover, at the end of the last trading period, the closing price was at $24.57.

    According to Raymond James, the prior rating for Toll Brothers Inc (NYSE:TOL) was changed from Outperform to Market Perform. In the third quarter, Toll Brothers showed an EPS of $2.35, compared to $1.87 from the year-ago quarter. The current stock performance of Toll Brothers shows a 52-week-high of $72.75 and a 52-week-low of $40.15. Moreover, at the end of the last trading period, the closing price was at $40.28.

    According to Raymond James, the prior rating for PulteGroup Inc (NYSE:PHM) was changed from Strong Buy to Market Perform. For the second quarter, PulteGroup had an EPS of $2.73, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $58.09 and a 52-week-low of $35.03. PulteGroup closed at $36.59 at the end of the last trading period.

    According to Raymond James, the prior rating for M.D.C. Holdings Inc (NYSE:MDC) was changed from Strong Buy to Market Perform. For the second quarter, M.D.C. Holdings had an EPS of $2.59, compared to year-ago quarter EPS of $2.11. The stock has a 52-week-high of $56.53 and a 52-week-low of $27.04. At the end of the last trading period, M.D.C. Holdings closed at $28.70.

    For Lennar Corp (NYSE:LEN), Raymond James downgraded the previous rating of Outperform to Market Perform. In the third quarter, Lennar showed an EPS of $5.18, compared to $3.27 from the year-ago quarter. The stock has a 52-week-high of $116.36 and a 52-week-low of $62.54. At the end of the last trading period, Lennar closed at $71.38.

    Raymond James downgraded the previous rating for KB Home (NYSE:KBH) from Strong Buy to Market Perform. KB Home earned $2.86 in the third quarter, compared to $1.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.20 and a 52-week-low of $24.78. KB Home closed at $26.48 at the end of the last trading period.

    For D.R. Horton Inc (NYSE:DHI), Raymond James downgraded the previous rating of Strong Buy to Outperform. D.R. Horton earned $4.67 in the third quarter, compared to $3.10 in the year-ago quarter. The stock has a 52-week-high of $108.64 and a 52-week-low of $59.25. At the end of the last trading period, D.R. Horton closed at $67.14.

    Raymond James downgraded the previous rating for Banner Corp (NASDAQ:BANR) from Strong Buy to Outperform. In the third quarter, Banner showed an EPS of $1.42, compared to $1.57 from the year-ago quarter. The current stock performance of Banner shows a 52-week-high of $69.67 and a 52-week-low of $52.35. Moreover, at the end of the last trading period, the closing price was at $67.29.

    SVB Leerink downgraded the previous rating for Immunic Inc (NASDAQ:IMUX) from Outperform to Market Perform. Immunic earned $0.72 in the second quarter, compared to $0.82 in the year-ago quarter. The stock has a 52-week-high of $14.50 and a 52-week-low of $2.52. At the end of the last trading period, Immunic closed at $9.20.

    For Zymeworks BC Inc (NYSE:ZYME), SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the second quarter, Zymeworks BC showed an EPS of $0.92, compared to $1.31 from the year-ago quarter. The current stock performance of Zymeworks BC shows a 52-week-high of $17.27 and a 52-week-low of $4.11. Moreover, at the end of the last trading period, the closing price was at $6.45.

    According to Janney Montgomery Scott, the prior rating for SVB Financial Group (NASDAQ:SIVB) was changed from Buy to Neutral. SVB Finl Gr earned $7.21 in the third quarter, compared to $6.24 in the year-ago quarter. The current stock performance of SVB Finl Gr shows a 52-week-high of $752.68 and a 52-week-low of $301.88. Moreover, at the end of the last trading period, the closing price was at $302.46.

    According to JP Morgan, the prior rating for Robert Half International Inc (NYSE:RHI) was changed from Overweight to Neutral. For the third quarter, Robert Half International had an EPS of $1.53, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $125.77 and a 52-week-low of $71.96. At the end of the last trading period, Robert Half International closed at $79.84.

    For Snap Inc (NYSE:SNAP), B of A Securities downgraded the previous rating of Buy to Neutral. For the third quarter, Snap had an EPS of $0.08, compared to year-ago quarter EPS of $0.17. The stock has a 52-week-high of $47.71 and a 52-week-low of $9.34. At the end of the last trading period, Snap closed at $10.79.

    According to Piper Sandler, the prior rating for SVB Financial Group (NASDAQ:SIVB) was changed from Overweight to Neutral. For the third quarter, SVB Finl Gr had an EPS of $7.21, compared to year-ago quarter EPS of $6.24. The current stock performance of SVB Finl Gr shows a 52-week-high of $752.68 and a 52-week-low of $301.88. Moreover, at the end of the last trading period, the closing price was at $302.46.

    For Cognizant Technology Solutions Corp (NASDAQ:CTSH), B of A Securities downgraded the previous rating of Buy to Neutral. Cognizant Tech Solns earned $1.14 in the second quarter, compared to $0.99 in the year-ago quarter. The stock has a 52-week-high of $93.47 and a 52-week-low of $55.40. At the end of the last trading period, Cognizant Tech Solns closed at $59.78.

    According to Bernstein, the prior rating for Snap Inc (NYSE:SNAP) was changed from Outperform to Market Perform. For the third quarter, Snap had an EPS of $0.08, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $47.71 and a 52-week-low of $9.34. Snap closed at $10.79 at the end of the last trading period.

    According to MKM Partners, the prior rating for Snap Inc (NYSE:SNAP) was changed from Buy to Neutral. For the third quarter, Snap had an EPS of $0.08, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $47.71 and a 52-week-low of $9.34. Snap closed at $10.79 at the end of the last trading period.

    According to Oppenheimer, the prior rating for NeuBase Therapeutics Inc (NASDAQ:NBSE) was changed from Outperform to Perform. In the third quarter, NeuBase Therapeutics showed an EPS of $0.26, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $3.18 and a 52-week-low of $0.27. At the end of the last trading period, NeuBase Therapeutics closed at $0.30.

    According to Stifel, the prior rating for Mister Car Wash Inc (NYSE:MCW) was changed from Buy to Hold. For the second quarter, Mister Car Wash had an EPS of $0.11, compared to year-ago quarter EPS of $0.14. The current stock performance of Mister Car Wash shows a 52-week-high of $19.10 and a 52-week-low of $8.21. Moreover, at the end of the last trading period, the closing price was at $8.40.

    According to Needham, the prior rating for Rapid7 Inc (NASDAQ:RPD) was changed from Buy to Hold. Rapid7 earned $0.01 in the second quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $118.42 and a 52-week-low of $38.36. Rapid7 closed at $45.28 at the end of the last trading period.

    For The Hain Celestial Group Inc (NASDAQ:HAIN), Piper Sandler downgraded the previous rating of Overweight to Neutral. For the fourth quarter, Hain Celestial Group had an EPS of $0.08, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $43.53 and a 52-week-low of $15.23. Hain Celestial Group closed at $15.97 at the end of the last trading period.

    RBC Capital downgraded the previous rating for Equifax Inc (NYSE:EFX) from Outperform to Sector Perform. Equifax earned $1.73 in the third quarter, compared to $1.85 in the year-ago quarter. At the moment, the stock has a 52-week-high of $294.93 and a 52-week-low of $149.13. Equifax closed at $150.24 at the end of the last trading period.

    For Mechel PAO (NYSE:MTL), RBC Capital downgraded the previous rating of Outperform to Sector Perform. NoneAt the moment, the stock has a 52-week-high of $4.32 and a 52-week-low of $1.88. Mechel PAO closed at $2.25 at the end of the last trading period.

    According to RBC Capital, the prior rating for Ovintiv Inc (NYSE:OVV) was changed from Outperform to Sector Perform. For the second quarter, Ovintiv had an EPS of $2.41, compared to year-ago quarter EPS of $1.11. At the moment, the stock has a 52-week-high of $63.30 and a 52-week-low of $33.59. Ovintiv closed at $50.15 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    Cantor Fitzgerald initiated coverage on Palo Alto Networks Inc (NASDAQ:PANW) with an Overweight rating. The price target for Palo Alto Networks is set to $220.00. For the fourth quarter, Palo Alto Networks had an EPS of $0.80, compared to year-ago quarter EPS of $0.53. The current stock performance of Palo Alto Networks shows a 52-week-high of $213.63 and a 52-week-low of $140.52. Moreover, at the end of the last trading period, the closing price was at $158.57.

    Cantor Fitzgerald initiated coverage on Zscaler Inc (NASDAQ:ZS) with a Neutral rating. The price target for Zscaler is set to $160.00. In the fourth quarter, Zscaler showed an EPS of $0.25, compared to $0.14 from the year-ago quarter. The current stock performance of Zscaler shows a 52-week-high of $323.55 and a 52-week-low of $125.12. Moreover, at the end of the last trading period, the closing price was at $150.23.

    With a Hold rating, Jefferies initiated coverage on Sol-Gel Technologies Ltd (NASDAQ:SLGL). The price target seems to have been set at $5.50 for Sol-Gel Technologies. For the second quarter, Sol-Gel Technologies had an EPS of $0.01, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $8.51 and a 52-week-low of $3.94. At the end of the last trading period, Sol-Gel Technologies closed at $4.76.

    With a Buy rating, UBS initiated coverage on Bruker Corp (NASDAQ:BRKR). The price target seems to have been set at $70.00 for Bruker. For the second quarter, Bruker had an EPS of $0.45, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $83.69 and a 52-week-low of $48.42. At the end of the last trading period, Bruker closed at $55.98.

    With a Neutral rating, UBS initiated coverage on Bloomin Brands Inc (NASDAQ:BLMN). The price target seems to have been set at $23.00 for Bloomin Brands. In the second quarter, Bloomin Brands showed an EPS of $0.68, compared to $0.81 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.51 and a 52-week-low of $15.89. Bloomin Brands closed at $21.17 at the end of the last trading period.

    Truist Securities initiated coverage on Air Transport Services Group Inc (NASDAQ:ATSG) with a Hold rating. The price target for Air Transport Services Gr is set to $26.00. In the second quarter, Air Transport Services Gr showed an EPS of $0.59, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $34.54 and a 52-week-low of $23.32. At the end of the last trading period, Air Transport Services Gr closed at $28.73.

    With an Outperform rating, RBC Capital initiated coverage on Axonics Inc (NASDAQ:AXNX). The price target seems to have been set at $85.00 for Axonics. In the second quarter, Axonics showed an EPS of $0.47, compared to $0.59 from the year-ago quarter. The current stock performance of Axonics shows a 52-week-high of $79.92 and a 52-week-low of $38.41. Moreover, at the end of the last trading period, the closing price was at $68.49.

    Barclays initiated coverage on CCC Intelligent Solutions Holdings Inc (NYSE:CCCS) with a Equal-Weight rating. The price target for CCC Intelligent Solutions is set to $10.00. In the second quarter, CCC Intelligent Solutions showed an EPS of $0.06, compared to $0.05 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.54 and a 52-week-low of $7.41. CCC Intelligent Solutions closed at $8.55 at the end of the last trading period.

    Cantor Fitzgerald initiated coverage on Cerberus Cyber Sentinel Corp (NASDAQ:CISO) with an Overweight rating. The price target for Cerberus Cyber Sentinel is set to $5.00. In the second quarter, Cerberus Cyber Sentinel showed an EPS of $0.05, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.00 and a 52-week-low of $2.15. Cerberus Cyber Sentinel closed at $3.02 at the end of the last trading period.

    Goldman Sachs initiated coverage on Workiva Inc (NYSE:WK) with a Buy rating. The price target for Workiva is set to $101.00. For the second quarter, Workiva had an EPS of $0.17, compared to year-ago quarter EPS of $0.07. The stock has a 52-week-high of $131.91 and a 52-week-low of $59.43. At the end of the last trading period, Workiva closed at $72.91.

    With a Buy rating, Goldman Sachs initiated coverage on Vertex Inc (NASDAQ:VERX). The price target seems to have been set at $20.00 for Vertex. Vertex earned $0.06 in the second quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Vertex shows a 52-week-high of $16.97 and a 52-week-low of $9.44. Moreover, at the end of the last trading period, the closing price was at $15.94.

    With a Sell rating, Goldman Sachs initiated coverage on BlackLine Inc (NASDAQ:BL). The price target seems to have been set at $57.00 for BlackLine. In the second quarter, BlackLine showed an EPS of $0.07, compared to $0.15 from the year-ago quarter. The current stock performance of BlackLine shows a 52-week-high of $104.64 and a 52-week-low of $49.66. Moreover, at the end of the last trading period, the closing price was at $56.63.

    With a Neutral rating, Goldman Sachs initiated coverage on E2open Parent Holdings Inc (NYSE:ETWO). The price target seems to have been set at $5.50 for E2open Parent Holdings. For the second quarter, E2open Parent Holdings had an EPS of $0.05, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $11.56 and a 52-week-low of $5.01. E2open Parent Holdings closed at $5.04 at the end of the last trading period.

    Goldman Sachs initiated coverage on Zuora Inc (NYSE:ZUO) with a Neutral rating. The price target for Zuora is set to $9.00. In the second quarter, Zuora showed an EPS of $0.03, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $18.80 and a 52-week-low of $6.13. At the end of the last trading period, Zuora closed at $7.05.

    With a Buy rating, Jefferies initiated coverage on Phathom Pharmaceuticals Inc (NASDAQ:PHAT). The price target seems to have been set at $16.00 for Phathom Pharmaceuticals. Phathom Pharmaceuticals earned $1.33 in the second quarter, compared to $1.00 in the year-ago quarter. The stock has a 52-week-high of $20.30 and a 52-week-low of $6.09. At the end of the last trading period, Phathom Pharmaceuticals closed at $9.92.

    With a Hold rating, Jefferies initiated coverage on Viatris Inc (NASDAQ:VTRS). The price target seems to have been set at $11.00 for Viatris. In the second quarter, Viatris showed an EPS of $0.88, compared to $0.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.60 and a 52-week-low of $8.42. Viatris closed at $9.34 at the end of the last trading period.

    Oppenheimer initiated coverage on Revolution Medicines Inc (NASDAQ:RVMD) with an Outperform rating. The price target for Revolution Medicines is set to $30.00. For the second quarter, Revolution Medicines had an EPS of $0.82, compared to year-ago quarter EPS of $0.60. At the moment, the stock has a 52-week-high of $27.49 and a 52-week-low of $14.08. Revolution Medicines closed at $17.68 at the end of the last trading period.

    Citigroup initiated coverage on Ormat Technologies Inc (NYSE:ORA) with a Neutral rating. The price target for Ormat Technologies is set to $91.00. For the second quarter, Ormat Technologies had an EPS of $0.22, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $98.47 and a 52-week-low of $60.32. At the end of the last trading period, Ormat Technologies closed at $83.69.

    Credit Suisse initiated coverage on Univar Solutions Inc (NYSE:UNVR) with an Outperform rating. The price target for Univar Solns is set to $31.00. In the second quarter, Univar Solns showed an EPS of $1.00, compared to $0.57 from the year-ago quarter. At the moment, the stock has a 52-week-high of $34.00 and a 52-week-low of $21.49. Univar Solns closed at $23.90 at the end of the last trading period.

    With an Underperform rating, Credit Suisse initiated coverage on Axalta Coating Systems Ltd (NYSE:AXTA). The price target seems to have been set at $20.00 for Axalta Coating Sys. For the second quarter, Axalta Coating Sys had an EPS of $0.41, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $34.12 and a 52-week-low of $20.66. Axalta Coating Sys closed at $22.78 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ACI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACI
    $ATSG
    $AXNX
    $AXTA

    CompanyDatePrice TargetRatingAnalyst
    Vertex Inc.
    $VERX
    2/12/2026$16.00Buy → Hold
    Jefferies
    Rapid7 Inc.
    $RPD
    2/11/2026$9.00Buy → Neutral
    UBS
    Rapid7 Inc.
    $RPD
    2/11/2026$10.00Buy → Hold
    Canaccord Genuity
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    Ovintiv Inc. (DE)
    $OVV
    2/3/2026$44.00Equal-Weight
    Stephens
    More analyst ratings

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vertex downgraded by Jefferies with a new price target

    Jefferies downgraded Vertex from Buy to Hold and set a new price target of $16.00

    2/12/26 7:24:07 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Rapid7 downgraded by UBS with a new price target

    UBS downgraded Rapid7 from Buy to Neutral and set a new price target of $9.00

    2/11/26 8:18:36 AM ET
    $RPD
    Computer Software: Prepackaged Software
    Technology

    Rapid7 downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Rapid7 from Buy to Hold and set a new price target of $10.00

    2/11/26 7:50:43 AM ET
    $RPD
    Computer Software: Prepackaged Software
    Technology

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Opaleye Management Inc. bought $5,800 worth of Ordinary Shares (100 units at $58.00) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    2/4/26 4:05:33 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Opaleye Management Inc. bought $5,705 worth of Ordinary Shares (100 units at $57.05) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    1/29/26 4:16:32 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Opaleye Management Inc. bought $187,356 worth of Ordinary Shares (3,324 units at $56.36) (SEC Form 4)

    4 - Sol-Gel Technologies Ltd. (0001684693) (Issuer)

    1/23/26 5:42:51 PM ET
    $SLGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACI
    $ATSG
    $AXNX
    $AXTA
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Zymeworks Inc.

    SCHEDULE 13G/A - Zymeworks Inc. (0001937653) (Subject)

    2/12/26 11:27:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Cognizant Technology Solutions Corporation

    10-K - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Filer)

    2/12/26 8:31:54 AM ET
    $CTSH
    EDP Services
    Technology

    Bloomin' Brands Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Bloomin' Brands, Inc. (0001546417) (Filer)

    2/12/26 8:01:53 AM ET
    $BLMN
    Restaurants
    Consumer Discretionary

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Murphy Robert C. sold $10,625,800 worth of shares (2,000,000 units at $5.31) and gifted 601,453 shares, decreasing direct ownership by 5% to 49,012,324 units (SEC Form 4)

    4 - Snap Inc (0001564408) (Issuer)

    2/10/26 9:00:03 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    SEC Form 4 filed by EVP, M&A and Corporate Affairs Moriarty Thomas M

    4 - Albertsons Companies, Inc. (0001646972) (Issuer)

    2/10/26 7:36:52 PM ET
    $ACI
    Food Chains
    Consumer Staples

    SEC Form 4 filed by Director Zinsner David

    4 - Albertsons Companies, Inc. (0001646972) (Issuer)

    2/10/26 7:36:16 PM ET
    $ACI
    Food Chains
    Consumer Staples

    $ACI
    $ATSG
    $AXNX
    $AXTA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Toll Brothers Announces Opening of New Community in Waxhaw, North Carolina

    WAXHAW, N.C., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest luxury home community  Toll Brothers at The Bluffs at Wesley Chapel, is now open in Waxhaw, North Carolina. This exclusive community features only 12 spacious home sites conveniently located near the area's best shopping, dining, and recreational options. Toll Brothers at The Bluffs at Wesley Chapel offers five stunning home designs ranging from 3,905 to over 5,200 square feet of luxury living space, with up to 6 bedrooms and 5.5 bathrooms. Designed for today's lifestyles, homes in this community include soaring two-story great rooms, d

    2/12/26 12:15:04 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    Robert Half Names Senior Leader to Drive Business Operations Modernization

    MENLO PARK, Calif., Feb. 12, 2026 /PRNewswire/ -- Global talent solutions and business consulting firm Robert Half (NYSE: RHI) has appointed Ryan Skubis to senior district president, business operations modernization. In this newly created role, Skubis will lead efforts to strengthen the company's operational infrastructure, advance technology adoption and accelerate strategic initiatives supporting teams and customers worldwide. Skubis joined Robert Half in 1999 and has held numerous leadership roles during his tenure. Most recently, he served as senior district president for

    2/12/26 11:15:00 AM ET
    $RHI
    Professional Services
    Consumer Discretionary

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Toll Brothers Announces New Luxury Home Community Coming Soon to Argyle, Texas

    ARGYLE, Texas, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest Dallas-area community, Toll Brothers at Furst Ranch, is coming soon to Argyle, Texas. This exclusive community will feature two collections of single-family homes on expansive 70- and 80-foot-wide home sites as well as access to an array of amenities within the 2,000-acre master plan. Site work is underway at Cross Timbers Road and SH 377 in Argyle, and the community is anticipated to open for sale in summer 2026. Toll Brothers at Furst Ranch will offer an array of contemporary home designs on oversized home sites, featuring flexible flo

    2/11/26 12:30:00 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    Toll Brothers Announces New Luxury Home Community Coming Soon to Nolensville, Tennessee

    NOLENSVILLE, Tenn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest Nashville-area community, Sagebrook by Toll Brothers, is coming soon to Nolensville, Tennessee. This highly anticipated community will be located on Clovercroft Road and Sagebrook Drive in Nolensville. Site development is underway and the community is anticipated to open for sale in fall 2026.Located less than a mile from historic downtown Nolensville, Sagebrook by Toll Brothers will feature 26 exquisite single-family homes. The all-new floor plans will include 4 to 5 spacious bedrooms and offer up to 4,883 square feet of elegant liv

    2/10/26 11:57:20 AM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Financials

    Live finance-specific insights

    View All

    Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

    Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted EPS of $0.59 FY25 revenues of $3.44 billion, up ~2% yoy, down ~4% organically FY25 GAAP diluted loss per share of $(0.15); non-GAAP diluted EPS of $1.83 Bruker initiates FY26 guidance: Revenues of $3.57 to $3.60 billion, up 4% to 5% yoy, with organic growth of 1% to 2% Non-GAAP EPS of $2.10 to $2.15, up 15% to 17% yoy, including an ~8% FX headwind Bruker Corporation (NASDAQ:BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025. Frank H. Laukien, Bruker's Presid

    2/12/26 7:00:00 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026

    VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its fourth quarter and full year 2025 financial results pre-market on March 2, 2026. Following the announcement, management will host a conference call and webcast to discuss financial results and provide a corporate update on March 2, 2026 at 8:30 am Eastern Time (ET). About Zymeworks Inc. Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a

    2/12/26 6:00:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GFL Environmental Reports Fourth Quarter and Full Year 2025 Results; Provides Full Year 2026 Guidance

    Fourth Quarter 2025 Results and Full Year 2025 Highlights Fourth quarter revenue, Adjusted EBITDA1 and Adjusted Free Cash Flow1 all ahead of expectationsFourth quarter Adjusted EBITDA margin1 of 30.2%, highest Q4 margin in Company's history, 110 basis points increase over the prior year period2 Full year revenue of $6,615.9 million, increase of 9.5% excluding the impact of divestitures3 (7.8% including the impact of divestitures)Full year Adjusted EBITDA1 of $1,985.0 million, increase of 12.8%2; Adjusted Net Income from continuing operations1 of $283.9 million; Net income from continuing operations of $241.1 millionFull year Adjusted EBITDA margin1 of 30.0%, first time in Company's history,

    2/11/26 4:08:00 PM ET
    $GFL
    Environmental Services
    Utilities

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Investment Alert: Stock Acquired at Air Transport Services Group Inc on Jun 7

    ```html Recently, on June 7, 2024, insider Berger Michael L made a significant purchase of Air Transport Services Group Inc shares, acquiring $49,830 worth of stock, which amounted to 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units and was disclosed in the SEC Form 4 filing "Berger Michael L bought $49,830 worth of shares (3,996 units at $12.47), increasing direct ownership by 4% to 103,705 units (SEC Form 4)". When analyzing this insider purchase in conjunction with other recent transactions within Air Transport Services Group Inc, several patterns emerge that could provide insights into the company's prospects and the conf

    6/10/24 12:24:42 AM ET
    $ATSG
    Air Freight/Delivery Services
    Consumer Discretionary

    $ACI
    $ATSG
    $AXNX
    $AXTA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Ormat Technologies Inc.

    SC 13D/A - ORMAT TECHNOLOGIES, INC. (0001296445) (Subject)

    12/13/24 4:05:21 PM ET
    $ORA
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13G/A filed by Zymeworks Inc.

    SC 13G/A - Zymeworks Inc. (0001937653) (Subject)

    11/14/24 9:00:57 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Immunic Inc.

    SC 13G/A - IMMUNIC, INC. (0001280776) (Subject)

    11/14/24 5:33:45 PM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care